share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:拟议出售证券
SEC announcement ·  04/04 10:35
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 04/04/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $4,364.80, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This upcoming transaction follows a pattern of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $313,511.68. The notice for the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 04/04/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $4,364.80, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This upcoming transaction follows a pattern of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $313,511.68. The notice for the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
正如在最近的一份文件中宣布的那样,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月4日出售3,968股A类股票。这些股票的总市值为4,364.80美元,最初于2022年7月10日作为限制性股票归属的一部分收购,是对向发行人提供的服务的补偿。这笔即将进行的交易遵循了过去三个月的销售模式,共出售了246,016股股票,总收益约为313,511.68美元。计划出售的通知与出售的同一天提交,该交易的计划已于2023年3月14日获得通过。
正如在最近的一份文件中宣布的那样,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月4日出售3,968股A类股票。这些股票的总市值为4,364.80美元,最初于2022年7月10日作为限制性股票归属的一部分收购,是对向发行人提供的服务的补偿。这笔即将进行的交易遵循了过去三个月的销售模式,共出售了246,016股股票,总收益约为313,511.68美元。计划出售的通知与出售的同一天提交,该交易的计划已于2023年3月14日获得通过。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息